Epperly Melissa B,
Insider CIK 1807359 · ROIV Director · ZNTL Chief Financial Officer · KNTE Director · NAUT Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-10-23 | 2026-10-27 | 116 | $36.49 | $4.2K | 15,351 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-10-23 | 2026-10-27 | 513 | — | $0 | 15,467 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-10-01 | 2026-10-05 | 17,750 | — | $0 | 151,416 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-10-01 | 2026-10-05 | 900 | $36.57 | $32.9K | 14,954 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-10-01 | 2026-10-05 | 16,850 | $36.08 | $607.9K | 15,854 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-10-01 | 2026-10-05 | 17,750 | $4.46 | $79.2K | 32,704 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2026-09-16 | 2026-09-18 | 10,531 | — | $0 | 10,531 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-09-16 | 2026-09-18 | 5,054 | — | $0 | 14,954 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2026-09-16 | 2026-09-18 | 10,531 | — | $0 | 10,531 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-09-16 | 2026-09-18 | 5,054 | — | $0 | 14,954 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-09-15 | 2026-09-17 | 600 | $40.38 | $24.2K | 9,900 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-09-15 | 2026-09-17 | 4,338 | $39.65 | $172.0K | 10,500 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-09-15 | 2026-09-17 | 600 | $40.38 | $24.2K | 9,900 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-09-15 | 2026-09-17 | 4,338 | $39.65 | $172.0K | 10,500 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-09-10 | 2026-09-14 | 2,179 | $40.94 | $89.2K | 14,838 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-09-10 | 2026-09-14 | 2,179 | $40.94 | $89.2K | 14,838 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-07-17 | 2026-07-21 | 543 | — | $0 | 17,017 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise deriv | 2026-06-29 | 2026-07-01 | 17,750 | — | $0 | 169,166 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-06-29 | 2026-07-01 | 15,002 | $34.32 | $514.9K | 19,222 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-06-29 | 2026-07-01 | 2,748 | $34.71 | $95.4K | 16,474 | SEC↗ |
| ROIV Roivant Sciences Ltd. | M Exercise | 2026-06-29 | 2026-07-01 | 17,750 | $4.46 | $79.2K | 34,224 | SEC↗ |
| NAUT Nautilus Biotechnology, In | A Award deriv | 2026-06-18 | 2026-06-22 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-04-17 | 2026-04-21 | 670 | — | $0 | 16,474 | SEC↗ |
| ROIV Roivant Sciences Ltd. | S Sale | 2026-03-16 | 2026-03-18 | 41,861 | $28.68 | $1.20M | 15,804 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2026-01-20 | 2026-01-22 | 815 | — | $0 | 57,719 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2026-01-20 | 2026-01-22 | 54 | $22.98 | $1.2K | 57,665 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-10-20 | 2025-10-22 | 1,056 | — | $0 | 56,904 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2025-09-10 | 2025-09-12 | 33,726 | — | $0 | 33,726 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-09-10 | 2025-09-12 | 14,524 | — | $0 | 57,509 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2025-09-10 | 2025-09-12 | 1,661 | $13.77 | $22.9K | 55,848 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-07-17 | 2025-07-21 | 1,609 | — | $0 | 42,985 | SEC↗ |
| NAUT Nautilus Biotechnology, In | A Award deriv | 2025-06-23 | 2025-06-25 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-04-17 | 2025-04-21 | 1,847 | — | $0 | 41,376 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2025-01-23 | 2025-01-27 | 1,672 | — | $0 | 39,709 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2025-01-23 | 2025-01-27 | 180 | $11.21 | $2.0K | 39,529 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2024-10-21 | 2024-10-23 | 1,613 | — | $0 | 38,037 | SEC↗ |
| ROIV Roivant Sciences Ltd. | J Other | 2024-09-12 | 2024-09-16 | 4,245 | $12.12 | $51.4K | 36,424 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2024-09-10 | 2024-09-12 | 27,894 | — | $0 | 27,894 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2024-09-10 | 2024-09-12 | 16,406 | — | $0 | 40,669 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2024-07-23 | 2024-07-25 | 1,702 | — | $0 | 24,263 | SEC↗ |
| NAUT Nautilus Biotechnology, In | A Award deriv | 2024-06-14 | 2024-06-17 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ROIV Roivant Sciences Ltd. | F Tax w/h | 2024-04-24 | 2024-04-26 | 123 | $10.90 | $1.3K | 22,561 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2024-04-24 | 2024-04-26 | 1,146 | — | $0 | 22,684 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 20,250 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 25,000 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 20,250 | — | $0 | 0 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | D To issuer deriv | 2024-04-03 | 2024-04-05 | 60,751 | — | $0 | 0 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2024-02-12 | 2024-02-12 | 2,573 | $11.44 | $29.4K | 451,449 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2024-02-02 | 2024-02-05 | 8,669 | $11.54 | $100.0K | 454,022 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2024-02-01 | 2024-02-05 | 75,000 | — | $0 | 75,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2024-02-01 | 2024-02-05 | 75,000 | — | $0 | 462,691 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2024-01-19 | 2024-01-23 | 1,207 | — | $0 | 21,538 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2023-10-16 | 2023-10-18 | 1,226 | — | $0 | 20,331 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-10-04 | 2023-10-06 | 4,594 | $19.43 | $89.3K | 388,579 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-10-04 | 2023-10-06 | 888 | $19.91 | $17.7K | 387,691 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2023-09-12 | 2023-09-14 | 26,595 | — | $0 | 26,595 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2023-09-12 | 2023-09-14 | 17,825 | — | $0 | 19,105 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award | 2023-07-03 | 2023-07-06 | 1,280 | — | $0 | 1,280 | SEC↗ |
| NAUT Nautilus Biotechnology, In | A Award deriv | 2023-06-15 | 2023-06-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2023-06-12 | 2023-06-13 | 25,000 | — | $0 | 25,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-02-14 | 2023-02-14 | 5,227 | $19.98 | $104.4K | 392,048 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2023-02-13 | 2023-02-14 | 2,624 | $20.42 | $53.6K | 397,275 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2023-02-01 | 2023-02-01 | 148,043 | — | $0 | 148,043 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2023-02-01 | 2023-02-01 | 101,957 | — | $0 | 399,899 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2022-10-03 | 2022-10-03 | 50,000 | — | $0 | 297,543 | SEC↗ |
| ROIV Roivant Sciences Ltd. | A Award deriv | 2022-07-20 | 2022-07-25 | 186,916 | — | $0 | 186,916 | SEC↗ |
| NAUT Nautilus Biotechnology, In | A Award deriv | 2022-06-15 | 2022-06-16 | 86,467 | — | $0 | 86,467 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2022-06-13 | 2022-06-15 | 20,250 | — | $0 | 20,250 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-04-04 | 2022-04-05 | 8,094 | $48.75 | $394.6K | 256,400 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-04-04 | 2022-04-05 | 1,303 | $49.90 | $65.0K | 255,097 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-04-04 | 2022-04-05 | 2,818 | $50.70 | $142.9K | 252,279 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-04-04 | 2022-04-05 | 4,512 | $51.99 | $234.6K | 247,767 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-04-04 | 2022-04-05 | 353 | $52.44 | $18.5K | 247,414 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-02-23 | 2022-02-23 | 702 | $49.59 | $34.8K | 264,494 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2022-02-23 | 2022-02-23 | 1,211 | $48.81 | $59.1K | 265,196 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2022-02-10 | 2022-02-14 | 38,489 | — | $0 | 38,489 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2022-02-10 | 2022-02-14 | 16,405 | — | $0 | 266,407 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | F Tax w/h | 2021-10-02 | 2021-10-04 | 17,080 | $67.13 | $1.15M | 250,002 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | P Buy | 2021-08-19 | 2021-08-20 | 8,285 | $52.00 | $430.8K | 266,685 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | P Buy | 2021-08-18 | 2021-08-20 | 1,326 | $52.00 | $69.0K | 258,400 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-01 | 2021-07-06 | 805 | $52.01 | $41.9K | 257,274 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-01 | 2021-07-06 | 200 | $53.19 | $10.6K | 257,074 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-01 | 2021-07-06 | 1,378 | $51.15 | $70.5K | 258,079 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-07-01 | 2021-07-06 | 700 | $50.10 | $35.1K | 259,457 | SEC↗ |
| KNTE Kinnate Biopharma Inc. | A Award deriv | 2021-06-11 | 2021-06-14 | 20,250 | — | $0 | 20,250 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-06-01 | 2021-06-02 | 200 | $54.90 | $11.0K | 260,157 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-06-01 | 2021-06-02 | 2,883 | $53.99 | $155.7K | 260,357 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-05-03 | 2021-05-05 | 350 | $56.99 | $19.9K | 265,973 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-05-03 | 2021-05-05 | 661 | $58.04 | $38.4K | 265,312 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-05-03 | 2021-05-05 | 950 | $59.83 | $56.8K | 264,362 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-05-03 | 2021-05-05 | 1,122 | $60.14 | $67.5K | 263,240 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-04-05 | 2021-04-06 | 13,792 | $43.37 | $598.2K | 266,555 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-04-05 | 2021-04-06 | 3,083 | $43.43 | $133.9K | 280,347 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-04-05 | 2021-04-06 | 149 | $44.21 | $6.6K | 266,406 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-04-05 | 2021-04-06 | 83 | $45.06 | $3.7K | 266,323 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-03-01 | 2021-03-03 | 3,083 | $41.67 | $128.5K | 283,430 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award deriv | 2021-02-11 | 2021-02-16 | 45,000 | — | $0 | 45,000 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2021-02-11 | 2021-02-16 | 15,000 | — | $0 | 286,513 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-02-01 | 2021-02-03 | 2,700 | $37.45 | $101.1K | 271,896 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-02-01 | 2021-02-03 | 383 | $38.33 | $14.7K | 271,513 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-01-04 | 2021-01-06 | 100 | $53.20 | $5.3K | 274,596 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-01-04 | 2021-01-06 | 800 | $50.36 | $40.3K | 276,879 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-01-04 | 2021-01-06 | 600 | $51.58 | $30.9K | 276,279 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2021-01-04 | 2021-01-06 | 1,583 | $52.73 | $83.5K | 274,696 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-07 | 2020-12-08 | 391 | $54.39 | $21.3K | 277,679 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-07 | 2020-12-08 | 119 | $50.84 | $6.0K | 284,024 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-07 | 2020-12-08 | 971 | $52.53 | $51.0K | 283,053 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-07 | 2020-12-08 | 4,983 | $53.71 | $267.6K | 278,070 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-04 | 2020-12-08 | 3,877 | $51.17 | $198.4K | 284,143 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-04 | 2020-12-08 | 3,343 | $50.76 | $169.7K | 288,020 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-02 | 2020-12-03 | 1,525 | $51.33 | $78.3K | 292,221 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-02 | 2020-12-03 | 700 | $50.34 | $35.2K | 293,746 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-02 | 2020-12-03 | 500 | $52.27 | $26.1K | 291,721 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-12-02 | 2020-12-03 | 358 | $53.17 | $19.0K | 291,363 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-11-23 | 2020-11-25 | 2,783 | $46.51 | $129.4K | 294,746 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | S Sale | 2020-11-23 | 2020-11-25 | 300 | $47.26 | $14.2K | 294,446 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | P Buy | 2020-04-07 | 2020-11-25 | 20,000 | $18.00 | $360.0K | 297,529 | SEC↗ |
| ZNTL Zentalis Pharmaceuticals, | A Award | 2020-04-07 | 2020-04-09 | 147,394 | — | $0 | 277,529 | SEC↗ |